SCLERODERMA PANEL Test
Test Cost: AED 490.0
Symptoms, Diagnosis, and Test Details
At DNA Labs UAE, we offer the SCLERODERMA PANEL Test to help diagnose and monitor the progression of scleroderma, a chronic autoimmune disease that affects the skin and connective tissues.
Test Components
- Scl-70
- Centromere Antibody
Price: 490.0 AED
Sample Condition
3 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery
Sample collected on Tue / Fri by 9 am will receive the report on the same day.
Method
The SCLERODERMA PANEL Test is performed using Enzyme Immunoassay.
Test Type
This test is used for the diagnosis of autoimmune disorders.
Doctor
This test is conducted by a Rheumatologist.
Test Department
The SCLERODERMA PANEL Test is conducted in the Genetic Lab.
Pre Test Information
No special preparation is required before undergoing this test.
Test Details
The SCLERODERMA PANEL Test is a blood test that helps in the diagnosis and monitoring of scleroderma. Scleroderma is a chronic autoimmune disease that affects the skin and connective tissues. The panel includes specific antibodies commonly found in individuals with scleroderma, such as anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (Scl-70), anti-RNA polymerase III antibodies, and anti-U3 RNP antibodies. These antibodies are produced by the immune system in response to abnormal activation of certain cells and proteins in the body, which is characteristic of scleroderma.
The presence and levels of these antibodies in the blood can help healthcare providers in making a diagnosis and determining the subtype of scleroderma a person may have. The SCLERODERMA PANEL Test is usually ordered when a person presents with symptoms suggestive of scleroderma, such as thickening and hardening of the skin, joint pain and stiffness, Raynaud’s phenomenon (discoloration of fingers and toes in response to cold), and internal organ involvement. It may also be used to monitor disease activity and response to treatment.
It’s important to note that while the SCLERODERMA PANEL Test can provide valuable information, it is not a definitive diagnostic test for scleroderma. A diagnosis is typically made based on a combination of clinical symptoms, physical examination findings, and other diagnostic tests, such as skin biopsy, lung function tests, and imaging studies.
Overall, the SCLERODERMA PANEL Test is a useful tool in the evaluation and management of individuals suspected of having scleroderma, providing additional information to aid in diagnosis and treatment decisions.
Test Name | SCLERODERMA PANEL Test |
---|---|
Components | *Scl-70 *CentromereAntibody |
Price | 490.0 AED |
Sample Condition | 3 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen. |
Report Delivery | Sample Tue / Fri by 9 am; Report Same day |
Method | Enzyme Immunoassay |
Test type | Autoimmune disorders |
Doctor | Rheumatologist |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details | The Scleroderma Panel test is a blood test used to help diagnose and monitor the progression of scleroderma, a chronic autoimmune disease that affects the skin and connective tissues. The panel typically includes several specific antibodies that are commonly found in individuals with scleroderma, including anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (Scl-70), anti-RNA polymerase III antibodies, and anti-U3 RNP antibodies. These antibodies are produced by the immune system in response to the abnormal activation of certain cells and proteins in the body, which is characteristic of scleroderma. The presence and levels of these antibodies in the blood can help healthcare providers in making a diagnosis and determining the subtype of scleroderma a person may have. The Scleroderma Panel test is usually ordered when a person presents with symptoms suggestive of scleroderma, such as thickening and hardening of the skin, joint pain and stiffness, Raynaud’s phenomenon (discoloration of fingers and toes in response to cold), and internal organ involvement. It may also be used to monitor disease activity and response to treatment. It’s important to note that while the Scleroderma Panel test can provide valuable information, it is not a definitive diagnostic test for scleroderma. A diagnosis is typically made based on a combination of clinical symptoms, physical examination findings, and other diagnostic tests, such as skin biopsy, lung function tests, and imaging studies. Overall, the Scleroderma Panel test is a useful tool in the evaluation and management of individuals suspected of having scleroderma, providing additional information to aid in diagnosis and treatment decisions. |